| 000 | 01604 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518092300.0 | ||
| 264 | 0 | _c20201218 | |
| 008 | 202012s 0 0 eng d | ||
| 022 | _a1950-6007 | ||
| 024 | 7 |
_a10.1016/j.biopha.2020.110015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJin, Zheng | |
| 245 | 0 | 0 |
_aGeniposide alleviates atherosclerosis by regulating macrophage polarization via the FOS/MAPK signaling pathway. _h[electronic resource] |
| 260 |
_bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _cMay 2020 |
||
| 300 |
_a110015 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAtherosclerosis _xdrug therapy |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 | _aDiet, High-Fat |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aIridoids _xpharmacology |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 |
_aMacrophages _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPlaque, Atherosclerotic _xdrug therapy |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-fos _xgenetics |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aLi, Junlong | |
| 700 | 1 | _aPi, Jianbin | |
| 700 | 1 | _aChu, Qingmin | |
| 700 | 1 | _aWei, Weichao | |
| 700 | 1 | _aDu, Zhiyi | |
| 700 | 1 | _aQing, Lijin | |
| 700 | 1 | _aZhao, Xinjun | |
| 700 | 1 | _aWu, Wei | |
| 773 | 0 |
_tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _gvol. 125 _gp. 110015 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopha.2020.110015 _zAvailable from publisher's website |
| 999 |
_c30756625 _d30756625 |
||